[at noodls] – Abbott Park, Illinois – Abbott (NYSE: ABT) today announced it has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here to view […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Abbott and AbbVie will present at financial conferences in January 2013. Abbott will present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Abbott announced today that the French Autorité des marchés financiers (AMF) has approved the prospectus filed by AbbVie Inc., its research-based pharmaceuticals … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here to view […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Testosterone is an important androgen hormone in the health and well-being of men and women. Testosterone levels are associated with sexual development, libido, protection … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here to view […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – The board of directors of Abbott today declared its 356th consecutive quarterly cash dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to shareholders … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Acute chest pain is one of the most common reasons people seek emergency care, and time is a critical factor in diagnosing and treating people who may be having a heart … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott […]
[Business Wire] – BETHESDA, Md. & TOKYO–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that its subsidiary, Sucampo AG, has received a $15 million milestone payment from Abbott’s (NYSE: … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here to view […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Abbott announced today that the Securities and Exchange Commission (SEC) has declared effective the Form 10 Registration Statement filed by AbbVie Inc., its research-based … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboardSee who Abbott is hiring next, click here to view […]
[at noodls] – Abbott Park, Illinois (NYSE: ABT) – Abbott announced today that the European Commission has approved HUMIRA® (adalimumab) for the treatment of pediatric patients aged 6 to 17 years with severe active Crohn’s … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboard […]
[Business Wire] – BETHESDA, Md.–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Abbott (NYSE: ABT) today announced the availability of AMITIZA ® (lubiprostone) in Japan, a prescription medicine … moreView todays social media effects on ABTView the latest stocks trending across Twitter. Click to view dashboard […]
